Net Cash Provided by (Used in) Operating Activities |
-8.68K |
USD |
+69.3% |
Q3 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
11.8K |
USD |
+33.1% |
Q3 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
|
Q1 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
11.2M |
shares |
|
Q1 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q1 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
8.39K |
USD |
-27.6% |
Q1 2024 |
Q3 2024 |
Deferred Tax Assets, Valuation Allowance |
11.2K |
USD |
+1.45% |
Q1 2024 |
Q3 2024 |
Deferred Tax Assets, Gross |
11.2K |
USD |
+1.45% |
Q1 2024 |
Q3 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
53.3K |
USD |
+1.45% |
Q1 2024 |
Q3 2024 |
Additional Paid in Capital |
104K |
USD |
|
Q1 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q1 2024 |
Q3 2024 |